Clinical ponder on needle therapy treatment of COVID-19: A convention for efficient survey and meta-analysis

Author(s): Panayides Andreas

COVID-19 is an intense respiratory irresistible infection, which makes individuals troublesome to breathe; in expansion, it is frequently went with by cerebral pain, olfaction, and taste clutters of the neurological signs. Needle therapy has been demonstrated to have a restorative impact on different neurologic appearances. This is considered to be planned to assess the adequacy and security of needle therapy for the neurologic appearances in COVID-19. Randomized controlled trials from December 2019 to July 2021 will be included without limitations on dialect or distribution date. PubMed, EMBASE, Cochrane Library, Web of Science, Chinese Biomedical Databases (CBM), China National Information Framework (CNKI), Wanfang database, and VIP database will be looked. Two analysts will freely select ponders, extricate information, and assess think about quality. Cochrane chance of inclination apparatus for randomized trials will be utilized to evaluate the chance of predisposition of included ponders. Factual examinations will be performed utilizing the Audit Director V.5.3 and stata 14.0.